Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00664755 · ClinicalTrials.gov registry record · Phase 2
Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity
A Phase 2 study of Nicotine Dependence, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT00664755: Completed Phase 2 study of Nicotine Dependence, sponsored by Medical University of South Carolina.
NCT00664755 is a Phase 2 study of Nicotine Dependence that has completed, run by Medical University of South Carolina. The registered enrollment target is 140 participants, below the 185-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00664755, a Phase 2 study of Nicotine Dependence, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a brief smoking cessation trial in women, comparing transdermal nicotine patch (TNP) versus varenicline.
Primary Outcome
Carbon monoxide (≤10 parts per million) verified abstinence during the last two weeks of treatment
Conditions Studied
Interventions
- DRUG varenicline
- DEVICE transdermal nicotine patch
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2007-07 |
| Est. Completion | 2013-12 |
| Phase | Phase 2 |
What the finished NCT00664755 record still lists
NCT00664755 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 185-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (24% lower).
The record links to 1 condition, with Nicotine Dependence appearing as the primary indexed condition, and to 2 interventions - of which varenicline is the first listed.
NCT00664755 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT00664755 about?
NCT00664755 is a clinical study titled "Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity". This is a brief smoking cessation trial in women, comparing transdermal nicotine patch (TNP) versus varenicline.
What is the current status of trial NCT00664755?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2007-07. Estimated completion is 2013-12.
What conditions does trial NCT00664755 study?
This clinical trial studies the following conditions: Nicotine Dependence.
What interventions are being tested in trial NCT00664755?
The interventions under investigation include: varenicline (DRUG), transdermal nicotine patch (DEVICE).
Who is sponsoring clinical trial NCT00664755?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00664755 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00664755's enrollment target sits among peer trials
140 26th of 67 higher than 41 of 67 other Nicotine Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nicotine Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Trial of Varenicline for E-cigarette Cessation
RECRUITING · Phase 2
-
N-acetylcysteine for Tobacco Use Disorder
COMPLETED · Phase 2
-
Targeted Interventions for Weight-Concerned Smokers
COMPLETED · Phase 2
-
Adaptive Pharmacotherapy for Smoking Cessation
COMPLETED · Phase 2
-
E-cigarette Nicotine Study
COMPLETED · Phase 2
-
Treatment of Smoking Among Individuals With PTSD
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia